Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Other Non-Current Assets of $988922.1 for Q4 2025, down 62.01% year-over-year from $2.6 million in Q4 2024, and down 58.27% quarter-over-quarter from $2.4 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Other Non-Current Assets (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Other Non-Current Assets for 3 consecutive years, with $988922.1 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 62.01% year-over-year to $988922.1; the TTM figure through Dec 2025 stood at $988922.1 (down 62.01% YoY), while the FY2025 annual figure was $1.0 million, down 60.85% from the prior year.
- Other Non-Current Assets fell to $988922.1 in Q4 2025 per ZYBT's latest filing, from $2.4 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.6 million in Q4 2024 and bottomed at $903323.6 in Q4 2023.
- Historically, Other Non-Current Assets has averaged $1.7 million across 3 years, with a median of $1.7 million in 2025.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets jumped 188.16% — and 2025, when it plunged 62.01%.
- Zhengye Biotechnology Holding's Other Non-Current Assets stood at $903323.6 in 2023, then surged by 188.16% to $2.6 million in 2024, then plunged by 62.01% to $988922.1 in 2025.
- Business Quant data shows ZYBT's Other Non-Current Assets at $988922.1 in Q4 2025, $2.4 million in Q2 2025, and $2.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 13.00 Mn |
| 10 | Zhengye Biotechnology Holding | 86.79 Mn | 79.48 Mn | - | 988,922.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 988,922.10 |
| Jun 30, 2025 | 2.37 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 903,323.61 |